坏死性小肠结肠炎
医学
益生菌
双歧杆菌
益生元
抗生素
免疫系统
失调
肠道菌群
小肠结肠炎
疾病
母乳喂养
殖民地化
免疫学
母乳喂养
微生物学
内科学
乳酸菌
儿科
生物
细菌
食品科学
遗传学
作者
Randi Jacobsen Bertelsen,Elizabeth T. Jensen,Tamar Ringel‐Kulka
标识
DOI:10.1016/j.bpg.2016.01.001
摘要
Gut colonization by beneficial bacteria in early life is necessary for establishing the gut mucosal barrier, maturation of the immune system and preventing infections with enteric pathogens. Mode of delivery, prematurity, breastfeeding, and use of antibiotics are some of many factors that have been described to influence early life colonization. Dysbiosis, the absence of normal colonization, is associated with many disease conditions. Pre- and probiotics are commonly used as supplementation in infant formula, such as prebiotic oligosaccharides for stimulation of Bifidobacterium growth aiming to mimic the high levels of these commensal bacteria in the gut of breastfed infants. Studies suggest that probiotic supplementation may be beneficial in prevention and management of disease (e.g., reducing the risk of necrotizing enterocolitis in preterm infants and treatment of acute gastroenteritis in children). Although these studies show promising beneficial effects, the long-term risks or health benefits of pre- and probiotic supplementation are not clear.
科研通智能强力驱动
Strongly Powered by AbleSci AI